ArticleAmerican journal of epidemiology2026
An alternative method for assessing the fragility of survival analysis results: a proof-of-concept study based on the log-rank test.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Misused P values and an excessive focus on significance have prompted calls for added robustness metrics. The fragility index (FI), which quantifies how many event status changes are needed to reverse statistical significance, serves as a useful complement. Although FI has been applied in various settings such as dose-finding trials and meta-analyses, its use in survival analysis is limited due to complexities like censoring, variable follow-up, and hazard assumptions. Existing FI adaptations for survival data often reassign individuals across intervention arms in randomized controlled trials (RCTs), diverging from FI's original philosophy and reducing clinical plausibility. We propose a modified FI for survival data (FIS) to assess the robustness of survival analysis results in RCTs. Rather than reassigning individuals between intervention and control groups, FIS preserves the foundational principles of the original FI by quantifying the minimum number of changes in outcome status, either events or censoring, needed to overturn statistical significance. To enhance flexibility and practical utility, we extend FIS to assess fragility in both directions: from statistically significant to nonsignificant results and vice versa. We demonstrate the performance of the proposed method through two real-world cases from RCTs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.